Victor’s Story: Anticoagulant-associated bruising in compensated cirrhosis with competing stroke risk
A 68-year-old retired electrical engineer looking for an explanation for new hand and forearm bruises after starting anticoagulation, mild gum bleeding, and no melena, hematemesis, weakness, or dizziness
Victor was a retired electrical engineer whose first explanation was that any bruise meant the anticoagulant had to be stopped immediately.
The decision changed when bruises appeared after a new prescription but there were no signs of major blood loss. The combination of new hand and forearm bruises after starting anticoagulation, mild gum bleeding, and no melena, hematemesis, weakness, or dizziness required a more specific evaluation.
Stable hemoglobin, platelets, renal function, and compensated liver status argued against active major hemorrhage. The timing supported medication-amplified superficial bruising, while atrial-fibrillation stroke risk made abrupt anticoagulant cessation unsafe.
The final plan used prescriber-coordinated anticoagulant dose and interaction review, elimination of unnecessary NSAIDs and supplements, fall precautions, liver follow-up, and an emergency bleeding plan without independent drug cessation. Follow-up measured safety, symptom resolution, objective recovery, and the risk of recurrence.
The safest answer was not simply ‘stop the blood thinner’; it was to balance bleeding evidence against stroke risk.